Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Cited by (1,000)

Items 401–500 of 1,000

1. The Protective Role of Ozone Therapy in Kidney Disease: A Review
   Luis-Fernando Delgadillo-Valero, Estefani Yaquelin Hernández Cruz, José Pedraza‐Chaverrí · 2023 · Life
2. SGLT2 Inhibitors—Sweet Success for Diabetic Kidney Disease?
   Ian H. de Boer, Steven E. Kahn · 2016 · Journal of the American Society of Nephrology
3. Rodent models of diabetic kidney disease: human translatability and preclinical validity
   Frederikke Emilie Sembach, Mette V. Østergaard, Niels Vrang, Bo Feldt‐Rasmussen, Keld Fosgerau, Jacob Jelsing, Lisbeth N. Fink · 2020 · Drug Discovery Today
4. A rapid LC–MS/MS method for simultaneous determination of berberine and irbesartan in rat plasma: Application to the drug–drug pharmacokinetic interaction study after oral administration in rats
   Hao Zhou, Wenyue Li, Ling Sun, Wenfang Li, Liu Qian · 2021 · Biomedical Chromatography
5. Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy
   Fanliang Zhang, Ruixue Guo, Wen Cui, Li Wang, Jing Xiao, Jin Shang, Zhanzheng Zhao · 2021 · Renal Failure
6. A study on the status of normoalbuminuric renal insufficiency among type 2 diabetes mellitus patients: A multicenter study based on a Chinese population
   Xiaomeng Jia, Li Zang, Ping Pang, Lina Jiang, Jin Du, Weijun Gu, Jianming Ba, Yiming Mu, Zhaohui Lyu · 2021 · Journal of Diabetes
7. Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis
   Heejin Jin, Ye An Kim, Young Lee, Seunghyun Kwon, Ah Ra, Sujin Seo, Sungho Won, Je Hyun Seo · 2023 · BMC Medicine
8. Health-related quality of life in hypertensive patients with chronic kidney disease in low and middle-income countries
   Wening Wulandari, Neily Zakiyah, Cherry Rahayu, Irma Melyani Puspitasari, Auliya A. Suwantika · 2025 · BMC Nephrology
9. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS
   Miho Shimizu, Kengo Furuichi, Tadashi Toyama, Tomoaki Funamoto, Shinji Kitajima, Akinori Hara, Daisuke Ogawa, Daisuke Koya, Kenzo Ikeda, Yoshitaka Koshino et al. · 2017 · Clinical and Experimental Nephrology
10. Evaluation of various equations for estimating renal function in elderly Chinese patients with type 2 diabetes mellitus
    Mei Guo, Jianying Niu, Xianwu Ye, Xiaojie Han, Ying Zha, Yang Hong, Hong Fang, Yong Gu · 2017 · Clinical Interventions in Aging
11. Animal Models and Renal Biomarkers of Diabetic Nephropathy
    Laura Pérez‐López, Mauro Boronat, Carlos Melián, Yeray Brito‐Casillas, Ana María Wägner · 2020 · Advances in experimental medicine and biology
12. Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?
    Nete Tofte, Frederik Persson, Peter R Rossing · 2020 · Journal of Nephrology
13. Personalizing Diabetes Management in Liver Transplant Recipients: The New Era for Optimizing Risk Management
    Brooks Richardson, Mohammad Qasim Khan, Sara Ann Brown, Kymberly D. S. Watt, Manhal J. Izzy · 2021 · Hepatology Communications
14. A gastro-resistant peptide from Momordica charantia improves diabetic nephropathy in db / db mice via its novel reno-protective and anti-inflammatory activities
    Pei-Yung Liao, Hsin‐Yi Lo, I-Chen Liu, Lun-Chien Lo, Chien‐Yun Hsiang, Tin‐Yun Ho · 2022 · Food & Function
15. The Dual Role and Therapeutic Implications of the Wnt/β-Catenin Pathway in Diabetic Kidney Disease
    Yilinuer Adeerjiang, Xiao-Xue Gan, Wenting Li, Qian Li, Yiqi Jiang, Xia Shuang ZHU, Chen-Ming Hu, Panxia Wang, Sheng Jiang · 2025 · International Journal of General Medicine
16. The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial
    Yasuyuki Okuda, Sadayoshi Ito, Naoki Kashihara, Kenichi Shikata, Masaomi Nangaku, Takashi Wada, Tomoko Sawanobori, Masataka Taguri · 2022 · Hypertension Research
17. Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria
    Ashish Sarraju, George L. Bakris, Christopher Paul Cannon, David Z.I. Cherney, ChandrasekharRao Venkata Damaraju, Gemma A. Figtree, Jagadish P. Gogate, Tom Greene, Hiddo J.L. Heerspink, James L. Januzzi et al. · 2022 · Journal of the American College of Cardiology
18. The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study of 26,809 patients from 5 primary hospitals in China
    Zhaoxiang Liu, Xianglan Li, Yanlei Wang, Yanxia Song, Qiang Liu, Junxia Gong, Wenshuang Fan, Chunmei Lv, Chenxiang Cao, Wenhui Zhao et al. · 2023 · Frontiers in Endocrinology
19. Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?
    Hong-Yan Yao, Zijing Li · 2023 · Frontiers in Endocrinology
20. Chronic Kidney Disease Management in Developing Countries
    Danielle A. Badro · 2023 · Springer eBooks
21. Sacubitril/valsartan ameliorates renal tubulointerstitial injury through increasing renal plasma flow in a mouse model of type 2 diabetes with aldosterone excess
    Haruomi Nishio, Akira Ishii, Hiroyuki Yamada, Keita P. Mori, Yukiko Hakariya Kato, Shoko Ohno, Takaya Handa, Sayaka Sugioka, Takuya Ishimura, Akie Ikushima et al. · 2023 · Nephrology Dialysis Transplantation
22. Management of Patients With Kidney Disease Undergoing Bariatric Surgery
    Aleksandra Kukla, Yogish C. Kudva, P Navrátil, Sukhdeep Singh Sahi, Roberto P. Benzo, David C. Fipps, Avery E. Erickson, Rachael R. Majorowicz, Matthew M. Clark, Carrie A. Schinstock et al. · 2024 · Mayo Clinic Proceedings
23. Attenuated kidney oxidative metabolism in young adults with type 1 diabetes
    Ye Ji Choi, Gabriel Mary Richard, Guanshi Zhang, Jeffrey B. Hodgin, Dawit Demeke, Yingbao Yang, Jennifer A. Schaub, Ian M. Tamayo, Bhupendra K. Gurung, Abhijit S. Naik et al. · 2024 · Journal of Clinical Investigation
24. Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
    Ian H. de Boer, George L. Bakris · 2018 · Diabetes Care
25. Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients
    Li Li, Yang Yuan, Xuejing Zhu, Xiaofen Xiong, Lingfeng Zeng, Shan Xiong, Na Jiang, Chenrui Li, Shuguang Yuan, Hui Xu et al. · 2019 · Journal of Diabetes
26. Epigenetic activation of CTGF transcription by high glucose in renal tubular epithelial cells is mediated by myocardin-related transcription factor A
    Jing Shao, Huihui Xu, Xiaoyan Wu, Yong Xu · 2019 · Cell and Tissue Research
27. Type 2 Diabetes and Chronic Conditions Disparities in Medicare Beneficiaries in the State of Michigan
    John M. Clements, Mariana Georgeta Rosca, Carla Cavallin, Shelby Falkenhagen, Thomas Ittoop, Christina Jung, Megan Mazzella, Joseph A. Reed, Megan Schluentz, Caleb VanDyke · 2020 · The American Journal of the Medical Sciences
28. Long-term complications of type 1 diabetes: what do we know and what do we need to understand?
    Claudia Anita Piona, Claudia VENTRICI, Loredana MARCOVECCHIO, Francesco CHIARELLI, Claudio MAFFEIS, Riccardo Bonfanti, Ivana Rabbone · 2021 · Minerva Pediatrics
29. Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy
    Hamad Ali, Mohamed Abu‐Farha, EMAN M.M. ALSHAWAF, Sriraman Devarajan, Yousif Bahbahani, Irina Al‐Khairi, Preethi Cherian, Zahra Khalil Alsairafi, Vidya Vijayan, Fahd Al‐Mulla et al. · 2022 · BMC Nephrology
30. The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease
    Kalie L. Tommerdahl, Jessica Kendrick, Petter Bjornstad · 2022 · Clinical Journal of the American Society of Nephrology
31. Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
    Yichuan Wu, Huanjia Lin, Yuan Tao, Ying Xu, Jiaqi Chen, Yijie Jia, Zongji Zheng · 2022 · Frontiers in Pharmacology
32. Effects of green tea extract on oxidative stress and renal function in diabetic individuals: A randomized, double-blinded, controlled trial
    Sáskia Ribeiro Vaz, Luiza Moreira Nogueira de Amorim, Pamella Vanessa Freitas de Nascimento, Valéria Soares Pigozzi Veloso, Marina Sayuri Nogueira, Inar Alves de Castro, João Felipe Mota, Patrícia Borges Botelho · 2018 · Journal of Functional Foods
33. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis
    Katsuhito Mori, Masanori Emoto, Masanori Abe, Masaaki Inaba · 2018 · Journal of Diabetes Science and Technology
34. Cardiovascular risk and chronic kidney disease: strategies for cardiac and renal protection. Interdisciplinary consensus
    Oksana M. Drapkina, Zhanna D. Kobalava, Marina Vladimirovna Shestakova, Irina Nikolaevna Bobkova, Ефремовцева Марина Алексеевна, Виллевальде Светлана Вадимовна, М. М. Batyushin, Yu. N. Belenkov, Andrey Vatazin, Albert S. Galyavich et al. · 2025 · CARDIOVASCULAR THERAPY AND PREVENTION
35. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders
    Jeremy Chung Bo Chiang, Ria Arnold, Roshan Dhanapalaratnam, Maria Panayiota Markoulli, Arun V. Krishnan · 2022 · Pharmaceuticals
36. FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus
    Wenfei Duan, Ruixiao Shi, Fang Yang, Zhoujunhao Zhou, Lihong Wang, Zhe Huang, Shufei Zang · 2023 · Cardiovascular Diabetology
37. Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis
    Ruixuan Jiang, Ernest H. Law, Zhou Zhou, Hongbo Yang, Eric Qiong Wu, Raafat Seifeldin · 2018 · Diabetes Therapy
38. Iodine nutrition status and its association with microvascular complications in urban dwellers with type 2 diabetes
    Chi Chen, Yi Chen, Hualing Zhai, Fangzhen Xia, Bing Han, Wen Zhang, Yuying Wang, Heng Wan, Ningjian Wang, Yingli Lu · 2020 · Nutrition & Metabolism
39. Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
    Sadanori Okada, Ken‐ichi Samejima, Masaru Matsui, Katsuhiko Morimoto, Riri Furuyama, Kaori Tanabe, Masahiro Eriguchi, Yasuhiro Akai, Yoshihiko Saito, Kazuhiko Tsuruya · 2020 · BMJ Open Diabetes Research & Care
40. Sept8/SEPTIN8 involvement in cellular structure and kidney damage is identified by genetic mapping and a novel human tubule hypoxic model
    Gregory R. Keele, Jeremy W. Prokop, Hong He, Katie Holl, John C. Littrell, Aaron W. Deal, Yunjung Kim, Patrick B. Kyle, Esinam M. Attipoe, Ashley C. Johnson et al. · 2021 · Scientific Reports
41. Microvascular Disease and Risk of Cardiovascular Events and Death From Intensive Treatment in Type 2 Diabetes
    David E. Kloecker, Kamlesh Khunti, Melanie Jane Davies, Dario Pitocco, Francesco Zaccardi · 2021 · Mayo Clinic Proceedings
42. Chronic Kidney Disease on Health-Related Quality of Life in Patients with Diabetes Mellitus: A National Representative Study
    Yun Soo Hong, Hoon Kim, Di Zhao, Ajin Cho · 2021 · Journal of Clinical Medicine
43. C3c deposition predicts worse renal outcomes in patients with biopsy‐proven diabetic kidney disease in type 2 diabetes mellitus
    Meng‐Rui Li, Zi‐Jun Sun, Dong‐Yuan Chang, Xiaojuan Yu, Su‐Xia Wang, Min Chen, Ming‐Hui Zhao · 2022 · Journal of Diabetes
44. Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis
    Wenwen Lin, Yayong Luo, Fang Liu, Hangtian Li, Qian Wang, Zheyi Dong, Xiangmei Chen · 2022 · Frontiers in Pharmacology
45. Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes
    Suyan Duan, Meng Zhou, Lu Fang, Chen Chen, Si Chen, Luhan Geng, Chengning Zhang, Honglei Guo, Ming Zeng, Bin Sun et al. · 2023 · Endocrine
46. Variability in glycated albumin levels predicts the progression of diabetic nephropathy
    Su Bin Park, Sang Soo Kim, In Joo Kim, Yoon Jeong Nam, Kang Hee Ahn, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Sang Heon Song, Ihm Soo Kwak et al. · 2017 · Journal of Diabetes and its Complications
47. The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ya Li Luo, Kai Lü, Gang Liu, Jing Wang, Irakoze Laurent, Xiaoli Zhou · 2018 · Clinical Drug Investigation
48. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease
    Yun Hu, Tingting Li, Wei Zhou, Tingting Lu, Feng-fei Li, Bo Ding, Bing-li Liu, Xiaojing Xie, Jianhua Ma · 2019 · Diabetes Research and Clinical Practice
49. Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease
    João Soares Felício, Maria Antônia Matos Araújo, Gabriela Nascimento de Lemos, Isabel Jacob Fernandes, Licia Oliveira Ruivo, E Chambouleyron, Lilian de Souza D’Albuquerque Silva, Caroline Filgueira Nunes, Gisely Mouta de Andrade Paes, Franciane Trindade Cunha de Melo et al. · 2025 · Cardiovascular Diabetology
50. Neutrophil extracellular traps and peptidylarginine deiminase 4–mediated inflammasome activation link diabetes to cardiorenal injury and heart failure
    Nicolas Schommer, Nicolas Gendron, Krystin Krauel, Stijn Van Bruggen, Pierre‐André Jarrot, Alexander Maier, William Chan, Harald F. Langer, Daniel Duerschmied, Dirk Westermann et al. · 2025 · European Heart Journal
51. Association of Eating Patterns and Diabetic Kidney Disease in Type 2 Diabetes: A Cross-Sectional Study
    Cíntia Côrte Real Rodrigues, Bárbara Pelicioli Riboldi, Ticiana da Costa Rodrigues, Roberta Aguiar Sarmento, Juliana Peçanha Antonio, Jussara Carnevale de Almeida · 2022 · Journal of Renal Nutrition
52. Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
    Masayuki Yamanouchi, Naoki Sawa, Tadashi Toyama, Miho Shimizu, Megumi Oshima, Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Yuki Oba, Daisuke Ikuma et al. · 2023 · Kidney International Reports
53. WTAP and METTL14 regulate the m6A modification of DKK3 in renal tubular epithelial cells of diabetic nephropathy
    Kang Fu, Chenyang Jing, Jin‐Song Shi, Shuya Mao, Rui Lu, Miao Yang, Yang Chen, Bin Qian, Yu Wang, Limin Li · 2024 · Biochemical and Biophysical Research Communications
54. Clinical Profile of Elderly Patients (Over 90 Years) with Type 2 Diabetes Seen at a Diabetes Center in South India
    Viswanathan Mohan, Anjana Ranjit Mohan, Ranjit Unnikrishnan I, Gupta Prasanna Kumar, Routary Philips, Saravanan Jebarani, Ulagamathesan Venkatesan, Ganesan Uma Sankari, Kumaradas Gini Venisha, Ashok Kumar Rajendran et al. · 2019 · Diabetes Technology & Therapeutics
55. The Effect of Diacerein on Type 2 Diabetic Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis
    Shizhe Guo, Xianshan Guo, Hongya Zhang, Xuane Zhang, Zhen Li · 2020 · Journal of Diabetes Research
56. Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
    Kyung‐Soo Kim, Sangmo Hong, Hong Yup Ahn, Cheol‐Young Park · 2020 · Diabetes Therapy
57. Prognostic evaluation model of diabetic nephropathy patients
    Xiao Tu, Na Luo, Yiqi Lv, Bijuan Wang, Yayu Li · 2021 · Annals of Palliative Medicine
58. Podocyte VEGF-A Knockdown Induces Diffuse Glomerulosclerosis in Diabetic and in eNOS Knockout Mice
    Delma Verón, Pardeep Kumar Aggarwal, Qi Li, Gilbert W. Moeckel, Michael J Kashgarian, Alda Tufró · 2022 · Frontiers in Pharmacology
59. Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease
    Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Maurizio Di Marco, Maria Teresa Di Martino, Francesca Scionti, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello et al. · 2022 · International Journal of Molecular Sciences
60. Relationship Between Plasma Growth Differentiation Factor 15 Levels and Complications of Type 2 Diabetes Mellitus: A Cross-sectional Study
    Xiaoyan Zhu, Yue Zhang, Fei Liang, Jieyun Yin, Lai Jiang, Wenyan Cai, Jianan Lu, Chen Zhang, Yue Xiao, Haoyue Teng et al. · 2022 · Canadian Journal of Diabetes
61. Renal Resistive Index: Revisited
    Theertha Kuttancheri, Sudha K Das, Manjunath Sanjeeva Shetty · 2023 · Cureus
62. Clinical characteristics and outcomes of the oldest old people with type 2 diabetes – perspective from a tertiary diabetes center in Thailand
    Yotsapon Thewjitcharoen, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Somboon Vongterapak, Anuntakulnatee Tawee, Worawit Kittipoom, Soontaree Nakasatien, Thep Himathongkam · 2016 · BMC Endocrine Disorders
63. Effect of AMP ‐activated protein kinase subunit alpha 2 (PRKAA2) genetic polymorphisms on susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a Chinese population
    Qingchu Li, Cuilin Li, Haoyun Li, Liu Zeng, Zhiqiang Kang, Yu Mao, Xinyue Tang, Panpan Zheng, Li He, Fang Luo et al. · 2017 · Journal of Diabetes
64. Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
    Yeung, Martin Ho Yin, Leung, Ka Long, Choi, Lai Yuen, Yoo, Jung Sun, Yung, Susan, So, Pui-Kin, Wong, Chi-Ming · 2022 · Frontiers in Pharmacology
65. Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies
    Reinhart Speeckaert, Charlotte Delrue, Marijn M. Speeckaert · 2026 · Journal of Clinical Medicine
66. Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
    Xiao Long Lin, Qiuyu Li, Hao Xuan Sun, Dong Hui Zhao, Jing Hua Liu, Qian Fan · 2022 · Frontiers in Cardiovascular Medicine
67. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate
    Jingya Niu, Xiaoyun Zhang, Mian Li, Shujing Wu, Ruizhi Zheng, Li Chen, Yanan Huo, Min Xu, Tiange Wang, Zhiyun Zhao et al. · 2023 · Diabetes & Metabolism
68. Status and trends in epidemiologic characteristics of diabetic end-stage renal disease: an analysis of the 2021 Korean Renal Data System
    Kyeong Min Kim, Seon A Jeong, Tae Hyun Ban, Yu Ah Hong, Seun Deuk Hwang, Sun Ryoung Choi, Hajeong Lee, Ji Hyun Kim, Su Hyun Kim, Tae Hee Kim et al. · 2024 · Kidney Research and Clinical Practice
69. Investigating Interleukin-6 Levels in Type 2 Diabetes Mellitus Patients With and Without Diabetic Nephropathy
    Vutukuru Kalyan Kumar Reddy, Govind S. Shiddapur, Nilesh Jagdale, Mohith Prakash Kondapalli, Saimounika Adapa · 2024 · Cureus
70. An arterial spin labeling−based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes
    Feier Ma, Xian Shao, Yuling Zhang, Jiatong Li, Qiuhong Li, Haizhen Sun, Tongdan Wang, Hongyan Liu, Feiyu Zhao, Lianqin Chen et al. · 2024 · Frontiers in Endocrinology
71. Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice
    Siyu Li, Jie Wang, Ying Chen, Yanlu Cheng, Yanan Wang, Nuowen Xu, Hao Wang, Li Wang, Yang-Feng Chi, Xiaoxue Ye et al. · 2025 · Inflammation
72. Cell cycle disorders in podocytes: an emerging and increasingly recognized phenomenon
    Chaojie Zhang, Jia Guo · 2025 · Cell Death Discovery
73. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs
    Faïza Lamine, Fabrice Lalubin, Nelly Pitteloud, Michel Burnier, Anne Zanchi · 2016 · Swiss Medical Weekly
74. Rapid Analysis and Guided Isolation of Astragalus Isoflavonoids by UHPLC–DAD–MSn and Their Cellular Antioxidant Defense on High-Glucose-Induced Mesangial Cell Dysfunction
    Dan Tang, Yingbin Shen, Zhi-Hua Wang, Bao He, Youhua Xu, Hong Nie, Quan Zhu · 2017 · Journal of Agricultural and Food Chemistry
75. Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease
    Clement Lo, Edward Zimbudzi, Helena Jane Teede, Peter G. Kerr, Sanjeeva Ranasinha, Alan Cass, Gregory R. Fulcher, Martin Gallagher, Kevan Roy Polkinghorne, Grant M. Russell et al. · 2018 · Journal of Diabetes and its Complications
76. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study
    Dahai Yu, Jin Shang, Yamei Cai, Zheng Wang, Xiaoxue Zhang, Bin Zhao, Zhanzheng Zhao, David S Simmons · 2019 · BMJ Open Diabetes Research & Care
77. Treatment strategies for hypertension in patients with type 1 diabetes
    Alexandra Katsimardou, Konstantinos P. Imprialos, Konstantinos Stavropoulos, Alexandros G. Sachinidis, Michael N. Doumas, Vasilios Gabriel Athyros · 2020 · Expert Opinion on Pharmacotherapy
78. Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
    Davida F. Kruger, Virginia Valentine · 2020 · Diabetes Therapy
79. CD‐1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis
    Yuiko Mizunuma, Keizo Kanasaki, Kyoko Nitta, Yuka Nakamura, Yasuhito Ishigaki, Yuta Takagaki, Munehiro Kitada, Shaolan Li, Haijie Liu, Jinpeng Li et al. · 2020 · Journal of Diabetes Investigation
80. Persistent Anxiety Is Associated with Higher Glycemia Post-Transition to Adult Services in Asian Young Adults with Diabetes
    Ling Zhu, SURESH RAMA CHANDRAN, Wee Boon Tan, Xiaohui Xin, Su‐Yen Goh, Daphne Su-Lyn Gardner · 2020 · Diabetes & Metabolism Journal
81. Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study
    Juan Ignacio Calvo Hueros, María Victoria Martín Hidalgo-Barquero, José Antonio Morales-Gabardino, Francisco Buitrago · 2020 · Primary care diabetes
82. Association of age at diabetes complication diagnosis with age at natural menopause in women with type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
    Yan Yi, Samar R. El Khoudary, Jeanine M. Buchanich, Rachel G. Miller, Debra Rubinstein, Trevor John Orchard, Tina Costacou · 2021 · Journal of Diabetes and its Complications
83. Plasma microRNA-192 expression as a potential biomarker of diabetic kidney disease in patients with type 2 diabetes mellitus
    Talaat Abd El Fattah Abdelaty, Eman Yousef Morsy, Eman Tayae Elsayed, Shimaa Mohamed Elrahmany, Sameh Aldesoky Anwar Lashen · 2020 · Clinical Diabetology
84. Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
    Jaehyun Bae, Young Jun Won, Byung‐Wan Lee · 2021 · Life
85. Diabetes mellitus and multiple myeloma; common features of two distinct entities
    Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos, Ioanna Eleftheriadou, Panagiotis Malandrakis, Evangelia Tzeravini, Maria Gavriatopoulou · 2022 · Diabetes/Metabolism Research and Reviews
86. Clinical Characteristics of Patients with Diabetic Nephropathy on Maintenance Hemodialysis
    Chen Hu, Deguang Wang, Yuan Liang, Guiling Liu, Heng-Jie He, Juan Wang, Sen Zhang, Hao Li · 2016 · Chinese Medical Journal
87. RSSDI consensus recommendations on insulin therapy in the management of diabetes
    Expert panel (extended), Rajeev Chawla, B. M. Makkar, S. Aggarwal, Sarita Bajaj, Ashok Kumar Das, Sujoy Kumar Ghosh, Arvind Gupta, Sunil Gupta, Shalini Jaggi et al. · 2019 · International Journal of Diabetes in Developing Countries
88. Clinical Implications of Estimating Glomerular Filtration Rate with Three Different Equations among Older People. Preliminary Results of the Project “Screening for Chronic Kidney Disease among Older People across Europe (SCOPE)”
    Andrea Corsonello, Regina Roller‐Wirnsberger, Gerhard Hubert Wirnsberger, Johan Ärnlöv, Axel Carl Carlsson, Lisanne Tap, Francesco U.S. Mattace-Raso, Francesç Formiga, Rafael Moreno‐González, Christian Weingart et al. · 2020 · Journal of Clinical Medicine
89. Complement Proteins Identify Rapidly Progressive Diabetic Kidney Disease
    Donghwan Yun, Sohyun Bae, Yuqian Gao, Lauren Lopez, Dohyun Han, Carrie Nicora, Tae Youn Kim, Kyung Chul Moon, Dong Ki Kim, Thomas Fillmore et al. · 2025 · Kidney International Reports
90. Low-molecular-weight fucoidan ameliorates ferroptosis in diabetic kidney disease through SLC7A11/GSH/GPX4 activation
    Xiaoxue Chen, Bin Niu, Zifan Zhang, Bo Zhang, Tao Xue, Yanjuan Liu, Zhen Wang, Xinpeng Li · 2025 · Fitoterapia
91. Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria
    Stein Ivar Hallan, Marius Altern Øvrehus, Manjula Darshi, Daniel Montemayor, Knut Asbjørn Rise Langlo, Per Bruheim, Kumar Sharma, the CRIC Study Investigators · 2023 · Kidney360
92. Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy
    Danping Xu, Chonghao Jiang, Yonggui Xiao, Hanlu Ding · 2023 · Frontiers in Genetics
93. Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim · 2024 · Diabetes & Metabolism Journal
94. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy
    Gemma E. Currie, Christian Delles · 2016 · Current Diabetes Reports
95. Low-intensity shockwave therapy in the treatment of diabetic nephropathy: a prospective Phase 1 study
    Sune Moeller Skov-Jeppesen, Knud Bonnet Yderstræde, Claus Bistrup, Boyle L Jensen, Niels Marcussen, Milad Hanna, Lars Christian Lund · 2018 · Nephrology Dialysis Transplantation
96. Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis
    Yi Liu, Hongguang Li, Shuzhi Wang, Weidong Yin, Zongbao Wang · 2020 · Biomedicine & Pharmacotherapy
97. Kidney Age Index (KAI): A novel age-related biomarker to estimate kidney function in patients with diabetic kidney disease using machine learning
    Sunil Belur Nagaraj, Lyanne M. Kieneker, Michelle J Pena · 2021 · Computer Methods and Programs in Biomedicine
98. Visit‐to‐visit variability in albuminuria predicts renal function deterioration in patients with type 2 diabetes
    Chih‐Hung Lin, Ying-Chuen Lai, Tien‐Jyun Chang, Yi‐Der Jiang, Yi‐Cheng Chang, Lee‐Ming Chuang · 2022 · Journal of Diabetes Investigation
99. Plasma or Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL): Which Is Better at Detecting Chronic Kidney Damage in Type 2 Diabetes?
    Marta Greco, EUSEBIO D. CHIEFARI, Maria Mirabelli, Alessandro Salatino, Vera Tocci, Paola Cianfrone, DANIELA PATRIZIA FOTI, Antonio Brunetti · 2022 · Endocrines
100. Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease
     Michele Provenzano, Federica Maritati, Chiara Abenavoli, Claudia Bini, Valeria Corradetti, Gaetano La Manna, Giorgia Comai · 2022 · International Journal of Molecular Sciences